Patents by Inventor Roger Boissonneault

Roger Boissonneault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9763887
    Abstract: A mesalamine pharmaceutical composition with reduced delivery variability for delivery of mesalamine to the colon that includes multiple dosage elements, and each dosage element includes mesalamine and an enteric coating. The enteric coating of each different dosage element differs so the release point of the mesalamine in the GI tract is varied. In one embodiment, a first dosage element releases about 30% to about 60% by weight of the total mesalamine in the composition after 60 minutes at a pH of about 6.6 in an aqueous phosphate buffer using a paddle apparatus 2 with a paddle speed of 100 rpm and a second dosage element releases about 40% to about 70% by weight of the total mesalamine after 60 minutes at a pH of about 7.2 in an aqueous phosphate buffer using a paddle apparatus 2 with a paddle speed of 100 rpm.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 19, 2017
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Ryan Gerald Loughlin, Stephen McCullagh, Roger Boissonneault
  • Publication number: 20140271859
    Abstract: A mesalamine pharmaceutical composition with reduced delivery variability for delivery of mesalamine to the colon that includes multiple dosage elements, and each dosage element includes mesalamine and an enteric coating. The enteric coating of each different dosage element differs so the release point of the mesalamine in the GI tract is varied. In one embodiment, a first dosage element releases about 30% to about 60% by weight of the total mesalamine in the composition after 60 minutes at a pH of about 6.6 in an aqueous phosphate buffer using a paddle apparatus 2 with a paddle speed of 100 rpm and a second dosage element releases about 40% to about 70% by weight of the total mesalamine after 60 minutes at a pH of about 7.2 in an aqueous phosphate buffer using a paddle apparatus 2 with a paddle speed of 100 rpm.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Ryan Gerald LOUGHLIN, Stephen MCCULLAGH, Roger BOISSONNEAULT
  • Publication number: 20070004690
    Abstract: A quadraphasic estrogenic/progestogenic contraceptive regimen that provides for a low level of estrogen in the initial phase and in the fourth phase is disclosed. Also described is a contraceptive kit that may be used to practice the method of the invention.
    Type: Application
    Filed: June 29, 2006
    Publication date: January 4, 2007
    Inventor: Roger Boissonneault
  • Publication number: 20060241091
    Abstract: A method of contraception that provides for sequentially administering to a female of child bearing age: (a) a first composition containing a progestin in an amount equivalent to about 0.3 to about 1.5 mg norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 20 mcg of ethinyl estradiol for about 22 to about 26 days; (b) a second composition containing an estrogen in an amount equivalent to about 5 to about 20 mcg of ethinyl estradiol for about 2 to about 3 days and an optional third composition that is a placebo provided that (i) if estrogen administration is continuous then the first composition is administered for 25 to 26 days, the second composition is administered for 2 to 3 days and no third composition is administered and (ii) if estrogen administration is not continuous then the first composition is administered for 22 to 24 days, the second composition is administered for 2 to 3 days and the third composition is administered for 1 to 4 days.
    Type: Application
    Filed: April 22, 2005
    Publication date: October 26, 2006
    Inventor: Roger Boissonneault
  • Publication number: 20060183719
    Abstract: The present invention is a solid dosage form of a metal complex of a tetracycline of Formula (I) for pharmaceutical administration, wherein R1=Cl, N(CH3)2, or H; R2=CH3, H, or CH2?; R3=CH3, H, OH, or absent; and R4=OH or H, with the proviso that if R2 is CH3 and R3 is H, then R4 is not OH.
    Type: Application
    Filed: January 20, 2006
    Publication date: August 17, 2006
    Inventors: Tina deVries, Roger Boissonneault, Brendan Muldoon
  • Publication number: 20050227952
    Abstract: A multiphasic method of contraception that provides for sequentially administering to a female of child bearing age: (a) a Phase I composition containing a progestogen in an amount equivalent to about 0.5 to about 1.5 mg norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 30 mcg of ethinyl estradiol for about 4 to about 7 days; (b) a Phase II composition containing a progestogen in an amount equivalent to about 0.5 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 10 to about 40 mcg of ethinyl estradiol for about 8 to about 16 days; (c) a Phase III composition containing a progestogen in an amount equivalent to about 0.5 to about 1.
    Type: Application
    Filed: March 14, 2005
    Publication date: October 13, 2005
    Inventor: Roger Boissonneault
  • Publication number: 20050176693
    Abstract: The present invention is a method of non-continuous administration of a pharmaceutical to a female for a condition associated with the female's menstrual cycle, comprising administering a daily placebo dosage, starting on the first or the second day of the menstrual cycle and continuing the daily administration for a placebo dosage period. Next administering a daily pharmaceutical dosage, starting on the day after the last daily placebo dosage was administered and continuing the daily administration of the pharmaceutical dosage for a pharmaceutical dosage period. Both the placebo dosages and the pharmaceutical dosages are contained in a single package.
    Type: Application
    Filed: February 15, 2005
    Publication date: August 11, 2005
    Inventors: Roger Boissonneault, Tina deVries, Herman Ellman, Kathryn MacFarlane, Kelly Smith
  • Publication number: 20050107351
    Abstract: A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the reduction or elimination of estrogen in the initial phase is disclosed. Also described is a contraceptive kit that may be used to practice the method of the invention.
    Type: Application
    Filed: November 12, 2004
    Publication date: May 19, 2005
    Inventor: Roger Boissonneault
  • Publication number: 20050038005
    Abstract: The present invention is a method of non-continuous administration of a pharmaceutical to a female for a condition associated with the female's menstrual cycle, comprising ascertaining a number of days in the female's menstrual cycle, and then administering a daily first dosage, starting on the first or the second day of the menstrual cycle and continuing the daily administration for a first dosage period. Next administering a daily second dosage, starting on the day after the last daily first dosage was administered and continuing the daily administration of the second dosage for a second dosage period. Wherein either the first dosage is a placebo and the second dosage is the pharmaceutical, or the first dosage is the pharmaceutical and the second dosage is a placebo. Both the first dosages and the second dosages being contained in a single package.
    Type: Application
    Filed: April 7, 2004
    Publication date: February 17, 2005
    Inventors: Roger Boissonneault, Tina deVries, Herman Ellman, Kathryn MacFarlane, Kelly Smith
  • Patent number: 4889236
    Abstract: A rigid, tripartite, credit card-style blister-pack medication package is disclosed which is particularly useful for dispensing medications which must be taken on a calendar day schedule. The package is of discrete design and may be conveniently carried in a purse or billfold.
    Type: Grant
    Filed: February 26, 1988
    Date of Patent: December 26, 1989
    Assignee: Warner-Lambert Company
    Inventors: Ralph Bartell, Roger Boissonneault, Monica Blischok